Emily Ricotta

Adjunct Assistant Professor

The George Washington University School of Medicine and Health SCiences

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Emily Ricotta is an Adjunct Assistant Professor at George Washington University School of Medicine and Health Sciences in the United States. Her research focuses on infectious diseases, particularly in relation to COVID-19 and the immune response in individuals with immunodeficiencies. Recent publications include studies on SARS-CoV-2 outcomes, observational research in epidemic settings, and the utilization of machine learning for risk factor identification.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Emily Edwards

MONASH UNIVERSITY

AUSTRALIA

View details

Menno van Zelm

Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Nicholas Evans

Associate Professor

University of Massachusetts Lowell

UNITED STATES

View details

Adia Benton

Northwestern University

UNITED STATES

View details

David Bending

University of Birmingham

UNITED KINGDOM

View details

Vincent Munster

Chief, Virus Ecology Section

NIAID Rocky Mountain Laboratories

UNITED STATES

View details

Ivan Cohen

Professor

Harvard Law School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emily Ricotta

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Breakthrough SARS-CoV-2 outcomes in immune-disordered people during the Omicron era: a prospective cohort study

Observational research in epidemic settings: a roadmap to reform

Voice EHR: introducing multimodal audio data for health.

Computable phenotypes to identify respiratory viral infections in the All of Us research program

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity

Observational studies must be reformed before the next pandemic

COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies.

Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.

Machine Learning in Infectious Disease for Risk Factor Identification and Hypothesis Generation: Proof of Concept Using Invasive Candidiasis

Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019.

Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study.

CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018

Prevalence of APECED-Like Clinical Disease in an Electronic Health Record Database, USA.

The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.

Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida

Missing diagnoses of congenital cytomegalovirus infection in electronic health records for infants with laboratory-confirmed infection.

Collaborators (7)

Emily Edwards

Menno van Zelm

Nicholas Evans

Adia Benton

David Bending

Vincent Munster

Ivan Cohen

Make your next move.